Dupixent Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumabs - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agents for dermatitis, excluding corticosteroids - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Nexviadyme Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

nexviadyme

sanofi b.v. - avalglucosidase alfa - glikogēna uzglabāšanas slimības ii tipa - citas gremošanas trakta un metabolisma produkti, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Xenpozyme Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

xenpozyme

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - citas gremošanas trakta un metabolisma produkti, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

Healthilife SEA KELP (Paziņots) tablete Latvia - Latvia - Pārtikas un veterinārais dienests, Zemkopības ministrija

healthilife sea kelp (paziņots) tablete

healthilife ltd. - tablete

Reconcile Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

reconcile

forte healthcare limited - fluoxetine - psihoanalētiskie līdzekļi - suņi - kā palīglīdzekli, ārstējot nodalīšanu saistītas slimības suņiem izpaužas iznīcināšanu un nepiedienīgu uzvedību (vocalisation un nepiemērotu attīrīšanas un / vai urinācija), un tikai kombinācijā ar uzvedības grozījumiem metodes.

Zerit Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

zerit

bristol-myers squibb pharma eeig - stavudine - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - grūti capsuleszerit ir norādīts kombinācijā ar citām pretvīrusu zālēm, lai ārstētu ar hiv inficētu pieaugušo pacientu un pediatrijas pacientiem (virs trīs mēnešu vecuma) tikai tad, kad citi antiretrovirals nevar izmantot. ilgums terapija ar zerit, būtu jāierobežo, lai pēc iespējas īsākā laikā. pulveris iekšķīgai solutionzerit ir norādīts kombinācijā ar citām pretvīrusu zālēm, lai ārstētu ar hiv inficētu pieaugušo pacientu un pediatrijas pacientiem (no dzimšanas) tikai tad, kad citi antiretrovirals nevar izmantot. ilgums terapija ar zerit, būtu jāierobežo, lai pēc iespējas īsākā laikā.

Flucinar 0,25 mg/g ziede Latvia - Latvia - Zāļu valsts aģentūra

flucinar 0,25 mg/g ziede

pharmaswiss ceska republika s.r.o., czech republic - fluocinolona acetonīds - ziede - 0,25 mg/g

Laticort 1 mg/g krēms Latvia - Latvia - Zāļu valsts aģentūra

laticort 1 mg/g krēms

pharmaswiss ceska republika s.r.o., czech republic - hidrokortizona butirāts - krēms - 1 mg/g

Lorinden A 0,2 mg/30 mg/g ziede Latvia - Latvia - Zāļu valsts aģentūra

lorinden a 0,2 mg/30 mg/g ziede

bausch health ireland limited, ireland - flumetasoni pivalas, skābes salicylicum - ziede - 0,2 mg/30 mg/g

Lorinden C 0,2 mg/30 mg/g ziede Latvia - Latvia - Zāļu valsts aģentūra

lorinden c 0,2 mg/30 mg/g ziede

pharmaswiss ceska republika s.r.o., czech republic - flumetasoni pivalas, clioquinolum - ziede - 0,2 mg/30 mg/g